top of page
Oct 18, 2023
2023-10-18: Published in Nikkei Business Daily "Biotech manufacturing, creating materials".
Our company's efforts were featured in the Nikkei Business Daily (electronic edition for Pro members only) in an article titled "(X Tech...
Sep 11, 2023
2023-09-11: Selected for the 2023 edition of Weekly Toyo Keizai's "100 Amazing Ventures"!
PtBio Inc. was selected for the 2023 edition of "100 Amazing Ventures" by Weekly Toyo Keizai (September 16-23, 2023). The "100 Amazing...
Jul 6, 2023
2023-06-22: Internship students from the University of Tokyo visit the head office!
Mr. Shuto Iwasaki, a second-year master's student in the Graduate School of Science at the University of Tokyo, who joined our company in...
Jul 4, 2023
2023-06-21:Selected for BRAIN "Comprehensive Support Program for Startups in FY2023 (SBIR Support)"!
The research project proposed by Dr. Kazuya Kiyokawa has been chosen for the "Comprehensive Support Program for Start-up Research (SBIR)"...
Jul 4, 2023
2023-06-20:Speaking engagement at the Google for Startups Hiroshima Startup Summit!
Mr. Atsuhiro Ishi, the COO of our company, had the privilege of speaking at the "Google for Startups Hiroshima Startup Summit". This...
Jul 4, 2023
2023-06-08:Poster Award at the 8th Annual Meeting of the Japanese Society for Genome Editi
Dr. Kazuki Nakamae was honored with the Poster Award at the 8th Annual Meeting of the Japanese Society for Genome Editing! <Title DANGER...
May 25, 2023
2023-05-25:Nikkei Shimbun's "Chugoku Region's Kirari Company"
Our company's efforts were featured in the article "PtBio Inc., Providing everything from genome analysis to editing technology - a...
Apr 28, 2023
2023-04-27: Hiroshima University and Kewpie confirmed safety of allergy-reduced eggs.
A joint research project between Hiroshima University and Kewpie Corporation has confirmed the safety of chicken eggs (allergy-reduced...
Apr 19, 2023
2023-04-19:PtBio has started applying Zinc Finger-based genome editing technology to drug discovery!
PtBio Inc. (headquarter: Higashihiroshima in Hiroshima, CEO: Keisuke Okuhara, hereinafter "PtB"), a bio-platformer that designs...
Mar 6, 2023
2023-03-06: "Bio-DX" project launched!
PtBio Inc. (headquarter: Higashihiroshima in Hiroshima, CEO: Keisuke Okuhara, hereinafter "PtB"), a platformer of genome editing...
bottom of page